Skip to main content

Predictors of atypical squamous cell of undetermined significance cervical cytology with high-risk human papilloma virus genotypes

Archives of Gynecology and Obstetrics volume 283, pages 343–348 (2011)Cite this article

Abstract

Objective

To investigate epidemiological factors that predicts high-risk human papillomavirus (HR-HPV) types among women with atypical squamous cells of undetermined significance (ASCUS).

Methods

Case–control study of women with ASCUS and ‘reflex’ HR-HPV DNA test results at the Prentice Ambulatory Care (PAC) outpatient clinic, Northwestern University, Chicago, USA. Univariate analysis and logistic regression were done to generate measures of association between various epidemiological variables and positive HR-HPV.

Results

A total of 2,539 women had liquid-based Pap smear and 126 (4.96%) were confirmed ASCUS. Of the 126 with ASCUS, 125 (99.2%) had ‘reflex’ HR-HPV results. The prevalence of HR-HPV among women with ASCUS was 43.2%. Among the 54 with a positive HR-HPV, 76.0% were women <30 years and 24.0% were ≥30 years. The prevalence of HR-HPV was 61.2% among women <30 years versus 22.4% among women ≥30 years (P < 0.001). The mean age and standard deviations (SD) was 26.5 (6.2 years) and 34.6 (10.2 years) for women with a positive HR-HPV and negative HR-HPV test, respectively (P < 0.001). Age category <30 years was independently predictive of HR-HPV (adjusted odds ratio 4.6, 95% CI 2.0–10.7; P < 0.001).

Conclusion

Age <30 years significantly predicts presence of HR-HPV types among women with diagnosis of ASCUS. A strategy of limiting HPV testing to older women and referral of those <30 years for colposcopic assessment appears more effective.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1

References

  1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108

    Article  PubMed  Google Scholar 

  2. Jemal A (2007) Cancer statistics 2007. CA Cancer J Clin 57:43–66

    Article  PubMed  Google Scholar 

  3. Myers E, Huh WK, Wright JD, Smith JS (2008) The current and future role of screening in the era of HPV vaccination. Gynecol Oncol 109:S31–S39

    Article  PubMed  Google Scholar 

  4. Milliez J (2008) Cervical cancer prevention and the millennium development goals. Bull WHO 86:6

    Google Scholar 

  5. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ (1995) Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 172:946–952

    CAS  Article  PubMed  Google Scholar 

  6. Kinney WK, Manos MM, Hurley LB, Ransley JE (1998) Where’s the high grade cervical neoplasia? The importance of minimally abnormal papanicolaou diagnoses. Obstet Gynecol 91:973–976

    CAS  Article  PubMed  Google Scholar 

  7. Wright TC Jr, Sun XW, Koulos J (1995) Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities. Obstet Gynecol 85:202–210

    CAS  Article  PubMed  Google Scholar 

  8. Wright TC Jr, Massad S, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D (2007) 2006 Consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 197:346–355

    Article  PubMed  Google Scholar 

  9. ASCUS-LSIL Triage Study (ALTS) Group (2003) Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. ASCUS-LSIL Triage Study (ALTS) Group. Am J Obstet Gynecol 188:1383–92

    Google Scholar 

  10. Spinillo A, Dal Bello B, Gardella B, Roccio M, Dacco MD, Silini EM (2010) Multiple human papillomavirus infection and high grade cervical intraepithelial neoplasia among women with cytological diagnosis of atypical squamous cells of undetermined significance of low grade squamous intraepithelial lesions. Gynecol Oncol. doi:10.1016/j.ygyno.2008.12.037 (in press)

  11. Ginocchio CC, Barth D, Zhang F (2008) Comparison of the third wave invader human papillomavirus (HPV) assay and the digene HPV hybrid capture 2 assay for detection of high-risk HPV DNA. J Clin Microbiol 5:1641–1646

    Article  Google Scholar 

  12. Solomon D, Davey D, Kurman R, Moriarty A, O’Connor D, Prey M et al (2002) The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 287:2114–2119

    Article  PubMed  Google Scholar 

  13. Sherman ME, Solomon D, Schiffman M, Qualification of ASCUS (2001) A comparison of equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study. Am J Clin Pathol 116:386–394

    CAS  Article  PubMed  Google Scholar 

  14. Boardman LA, Stanko C, Weitzen S, Sung CJ (2005) Atypical squamous cells of undetermined significance: human papillomavirus testing in adolescents. Obstet Gynecol 105:741–746

    Article  PubMed  Google Scholar 

  15. Sherman ME, Schifman M, Cox JT, Group TA (2002) Effects of age and HPV load on colposcopic triage: data from the ASCUS LSIL Triage Study (ALTS). J Natl Cancer Inst 94:102–107

    PubMed  Google Scholar 

  16. Bruner KS, Davey DD (2004) ASCUS and HPV testing in women aged 40 years and older. Diagn Cytopathol 31:358–361

    Article  PubMed  Google Scholar 

  17. Stoler MH, Schiffman M (2001) Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA 285:1500–1505

    CAS  Article  PubMed  Google Scholar 

  18. Confortini M, Carozzi F, Dalla Palma P (2003) Interlaboratory reproducibility of atypical squamous cells of undetermined significance report: a national survey. Cytopathology 14:263–268

    CAS  Article  PubMed  Google Scholar 

  19. Gatscha RM, Abadi M, Babore S, Chieng D, Miller MJ, Saigo PE (2001) Smears diagnosed as ASCUS: interobserver variation and follow-up. Diagn Cytopathol 25:138–140

    CAS  Article  PubMed  Google Scholar 

  20. Jones BA, Novis DA (2000) Follow-up of abnormal gynecologic cytology: a college of American pathologist Q-probes study of 16132 cases from 306 laboratories. Arch Pathol Lab Med 124:1605–1610

    Google Scholar 

  21. ACOG Practice Bulletin No (2009) 109: Cervical Cytology Screening. Obstet Gynecol 114:1409–1420

    Google Scholar 

  22. Palefsky JM, Holly EA (2003) Immunosuppression and co-infection with HIV, Chap. 6. J Natl Cancer Inst Monogr 31:41–46

    PubMed  Google Scholar 

  23. Chaturvedi AK, Dumestre J, Gaffga AM, Mire KM, Clark RA, Braly PS et al (2005) Prevalence of human papillomavirus genotypes in women from three clinical settings. J Med Virol 75:105–113

    Article  PubMed  Google Scholar 

  24. Duerr A, Paramsothy P, Jamieson DJ, Heilig CM, Klein RS, Cu-Uvin S, For the HIV Epidemiology Research Study et al (2006) Effect of HIV infection on atypical squamous cells of undetermined significance. Clin Inf Dis 42:855–861

    Article  Google Scholar 

  25. Moodley JR, Hoffman M, Carrara H, Allan BR, Cooper DD, Rosenberg L (2006) HIV and pre-neoplastic and neoplastic lesions of the cervix in South Africa: a case–control study. BMC Cancer 6:135. http://www.biomedcentral.com/1471-2407/6/135

    Google Scholar 

  26. Khan MJ, Partridge EE, Wang SS, Schiffman M, For the ALTS Study Group (2005) Socioeconomic status and the risk of cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mild abnormal cytology. Cancer 104:61–70

    Google Scholar 

  27. Rowhani-Rahbar A, Hawes SE, Salif Sow P, Toure P, Feng Q, Dem A et al (2007) The impact of HIV status and type on the clearance of human papillomavirus infection among Senegalese women. J Infect Dis 196(15):887–894

    Article  PubMed  Google Scholar 

  28. Wright TC, Massad LS, Twiggs LB, Wilkinson EJ (2002) 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 287:2120–2129

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Jonah Musa received financial support for training in Clinical Investigations from the Northwestern University AIDS International Training and Research Program (NU-AITRP) of the Fogarty International Center, National Institutes of Health (ID43TW007995-01A1).

Conflicts of interest statement

The authors have no conflict of interest to declare.

Author information

Affiliations

  1. Division of Infectiuous Diseases, Northwestern University, Chicago, IL, 60611, USA

    Jonah Musa, Babafemi Taiwo, Sarah Sutton, Baiba Berzins & Robert L. Murphy

  2. Prentice Women Hospital, Northwestern University, Chicago, IL, 60611, USA

    Susan Goldsmith

  3. Department of Obstetrics and Gynecology, Jos University Teaching Hospital, Jos, Nigeria

    Jonah Musa

Authors
  1. Jonah Musa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Babafemi Taiwo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Susan Goldsmith
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sarah Sutton
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Baiba Berzins
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Robert L. Murphy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jonah Musa.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Musa, J., Taiwo, B., Goldsmith, S. et al. Predictors of atypical squamous cell of undetermined significance cervical cytology with high-risk human papilloma virus genotypes. Arch Gynecol Obstet 283, 343–348 (2011). https://doi.org/10.1007/s00404-010-1421-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-010-1421-5

Keywords

  • Predictors
  • HR-HPV types
  • ASCUS
  • Cervical cytology